Antiparkinsonian therapy
Calne, D.B.
Primary Care 4(3): 533-539
1977
ISSN/ISBN: 0095-4543 PMID: 264228 Document Number: 115995
Powerful new tools for the treatment of parkinsonism include levodopa, decarboxylase inhibitors, and dopaminergic agonists. Yet earlier drugs still have a useful role to play. The decision to begin pharmacotherapy must be adjusted individually for each patient.
Document emailed within 1 workday
Related Documents
Rascol, A.; Montastruc, J.L.; Rascol, O. 1989: Antiparkinsonian drugs La Revue du Praticien 39(8): 663-669Murata, M. 2010: Discovery of an antiparkinsonian drug: zonisamide Rinsho Shinkeigaku 50(11): 780-782
Zebrowska-Lupina, I.; Porowska, A.; Pietrasiewicz, T. 1985: Interaction of antidepressants with antiparkinsonian agents in rats Polish Journal of Pharmacology and Pharmacy 37(6): 865-874
Gautier, J.; Jus, A.; Villeneuve, A.; Jus, K.; Pires, P.; Villeneuve, R. 1977: Influence of the antiparkinsonian drugs on the plasma level of neuroleptics Biological Psychiatry 12(3): 389-399
Kuwana, Y.; Shiozaki, S.; Kanda, T.; Kurokawa, M.; Koga, K.; Ochi, M.; Ikeda, K.; Kase, H.; Jackson, M.J.; Smith, L.A.; Pearce, R.K.; Jenner, P.G. 1999: Antiparkinsonian activity of adenosine A2A antagonists in experimental models Advances in Neurology 80: 121-123
Kumar, P.; Agarwal, J.C.; Nath, C.; Bhargava, K.P.; Shanker, K. 1981: Substituted dopamine quinazolones as potent antiparkinsonian agents Die Pharmazie 36(11): 780
Val'dman, E.A.; Voronina, T.A.; Aksenova, L.N.; Buneeva, O.A.; Medvedev, A.E. 2003: Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity Eksperimental'naia i Klinicheskaia Farmakologiia 66(5): 3-5
Srivastava, V.K.; Singh, S.; Palit, G.; Shanker, K. 1986: 1-[4-(4,5-dihydro-1H-imidazol-2-yl)aminophenyl]-3-(substituted phenyl)-2-propene-1-one as antiparkinsonian agents Die Pharmazie 41(8): 598-599
Molnár, G.; Lázár, I.; Szabó, I. 1971: Severe acute poisoning from a combination of antiparkinsonian drugs (L-dopa, Parkan, Aparkazin) Orvosi Hetilap 112(37): 2225-2227
Hazin, R.; Dixon, J.A.; Bhatti, M.T. 2009: Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Current Opinion in Ophthalmology 20(3): 210-218
Tani, M.; Yamaue, H. 2012: Multidisciplinary therapy for pancreatic cancer - clinical impact for preoperative therapy and peptide vaccine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 364-367
Kitamura, T.; Maruyama, T.; Nakamura, H.; Hayashi, K.; Shigehira, M.; Iwaki, Y.; Okamoto, T.; Ishikawa, T.; Ishinoda, Y.; Kisanuki, H. 1990: Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Part 1): 1467-1471
1983: Pathogenesis, diagnosis and therapy of ulcer diseases. 6. Therapy. Pharmacologic principles and antacid therapy Die Medizinische Welt 34(47): 14-18
Soma, I.; Hasuike, Y.; Hayashi, N.; Fukuchi, N.; Izawa, H.; Yoshida, T.; Ebisui, C.; Sakita, I.; Fujimoto, T.; Koshino, T.; Izumiyama, K. 2004: A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1903-1905
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Li, J.-m.; Yu, J.-m.; Liu, S.-w.; Chen, Q.; Mu, X.-k.; Jiang, Q.-a.; Zhao, M.-h.; Zhang, J.-g. 2009: Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy Zhonghua Yi Xue Za Zhi 89(45): 3201-3206
Shin, S.; Muñoz, M.; Zeladita, J.; Slavin, S.; Caldas, A.; Sanchez, E.; Callacna, M.; Rojas, C.; Arevalo, J.; Sebastian, J.L.; Bayona, J. 2011: How does directly observed therapy work? the mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru Health and Social Care in the Community 19(3): 261-271
Ramsay, D.L. 1995: Position paper: use of occupational therapy aides in occupational therapy practice. American Occupational Therapy Association American journal of occupational therapy: official publication of the American Occupational Therapy Association 49(10): 1023-1025
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157